All News

FDA considers relaxing dietary supplement warning labels, raising concerns about consumer safety and informed decision-making among users.

Oncology advances in 2025 highlight transformative therapies and the vital role of pharmacists in enhancing patient care and treatment outcomes.

A severe yet often overlooked coinfection with hepatitis B, hepatitis D progresses rapidly—but new therapies are beginning to reshape a long-limited treatment landscape.

Researchers develop a novel therapy combining molecular glues and KRAS inhibitors, showing promise in treating KRAS-mutant non–small cell lung cancer.

GLP-1 receptor agonists show potential in reducing alcohol cravings and addiction behaviors, offering hope for treating substance use disorders.

Expert highlights the critical need to manage skin toxicities in oncology, ensuring effective cancer treatments while addressing patient well-being and adherence.

The FDA approval of Boncresa and Oziltus, new denosumab biosimilars, enhances access to treatments for osteoporosis and cancer-related bone loss.

New research links ultra-processed foods, especially processed meats, to higher breast cancer mortality among Black women, highlighting dietary changes for better outcomes.

Pharmacists play a vital role in the safe integration of psychedelics into healthcare, addressing ethical concerns and ensuring equitable access to treatments.

New research highlights the efficacy and safety of HRS-1780, an investigational nonsteroidal MRA, in treating chronic kidney disease (CKD).

New findings on nodal radiation for breast cancer patients highlight the importance of lymph node involvement and tumor size in treatment decisions.

A long-term study reveals that high-fat cheese consumption may lower dementia risk, challenging traditional views on dietary fat and brain health.

Prolonged exposure to specific air pollution components significantly increases depression risk in older adults, highlighting the need for targeted regulations.

The FLEX study enhances breast cancer treatment by integrating genomic data, guiding therapy choices, and improving patient outcomes.

Research reveals that wildfire smoke exposure significantly impacts pediatric asthma control in the northeastern US, highlighting urgent climate health concerns.

Research reveals that adults who were hospitalized with RSV experience significant long-term health issues, impacting quality of life and physical function.

Pharmacists must adapt to the evolving landscape of psychedelic therapies, focusing on education, patient support, and understanding regulatory challenges.

Discover the latest FDA-approved treatments, including lumateperone for depression and elinzanetant for menopause symptoms, plus innovative health supplements.

Effective SCD pain management requires an integrated, multimodal strategy across outpatient and inpatient settings.

Pharmacists can play a pivotal role in overcoming the many challenges that exist in accessing immunomodulatory drugs in multiple myeloma.

New research explores the gut-brain connection, suggesting that improving gut health may enhance mental well-being.

Pimavanserin offers a serotonin-targeted option for Parkinson disease psychosis that improves hallucinations and delusions with minimal impact on motor symptoms.

A promising multistage malaria vaccine shows potential for broader protection against the disease, highlighting the evolving role of pharmacists in vaccination efforts.

High levels of C-reactive protein in the blood and lower heart rate variability were linked to cardiovascular events in patients with depression, anxiety, or both.

The FDA approved mitapivat, the first oral therapy for thalassemia due to anemia, offering hope for patients with transfusion-dependent and non–transfusion-dependent forms.

FDA approves mosunetuzumab's subcutaneous formulation, enhancing treatment access for relapsed follicular lymphoma.

UCSF pharmacists unveil an AI tool, Foghorn, enhancing investigational drug trials by streamlining processes and minimizing delays in drug development.